These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 28332361

  • 41. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z.
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract] [Full Text] [Related]

  • 42. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
    Baghbanian M, Halvani M, Roghani HS, Lotfi MH, Yazdi MF, Vahedian-Ardakani HA.
    Arq Gastroenterol; 2016 Oct; 53(3):175-9. PubMed ID: 27438423
    [Abstract] [Full Text] [Related]

  • 43. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 44. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [Abstract] [Full Text] [Related]

  • 45. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

  • 46. Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.
    Feeney SA, McCaughey C, Watt AP, Agnaf MR, McDougall N, Wend UC, Gerlich WH, Coyle PV.
    J Med Virol; 2013 Apr; 85(4):597-601. PubMed ID: 23359331
    [Abstract] [Full Text] [Related]

  • 47. Prevalence of "anti-HBc alone" among Syrian blood donors.
    Muselmani W, Habbal W, Monem F.
    J Infect Dev Ctries; 2014 Aug 13; 8(8):1013-5. PubMed ID: 25116667
    [Abstract] [Full Text] [Related]

  • 48. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.
    Almeida RW, Mello FCDA, Menegoy IV, Santo MPDE, Ginuíno CF, Sousa PSF, Villar LM, Lampe E, Lewis-Ximenez LL.
    Mem Inst Oswaldo Cruz; 2017 Jul 13; 112(7):485-491. PubMed ID: 28591309
    [Abstract] [Full Text] [Related]

  • 49. Mutation in the S gene a determinant of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in Northeastern Brazil.
    de Campos Albuquerque I, Sousa MT, Santos MD, Nunes JD, Moraes MJ, Gomes-Gouvêa MS, Pinho JR, Carrilho FJ, Fonseca LM, de Sousa Paiva Ferreira A.
    J Med Virol; 2017 Mar 13; 89(3):458-462. PubMed ID: 27486854
    [Abstract] [Full Text] [Related]

  • 50. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
    Song EY, Yun YM, Park MH, Seo DH.
    Intervirology; 2009 Mar 13; 52(2):57-62. PubMed ID: 19401629
    [Abstract] [Full Text] [Related]

  • 51. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A.
    Intervirology; 2008 Mar 13; 51(4):270-4. PubMed ID: 18841029
    [Abstract] [Full Text] [Related]

  • 52. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population.
    Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, Panduro A.
    J Med Virol; 2010 Sep 13; 82(9):1527-36. PubMed ID: 20648606
    [Abstract] [Full Text] [Related]

  • 53. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 13; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 54. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y, Marusawa H, Egawa H, Okamoto S, Ogura Y, Oike F, Nishijima N, Takada Y, Uemoto S, Chiba T.
    Antivir Ther; 2011 Dec 13; 16(4):479-87. PubMed ID: 21685535
    [Abstract] [Full Text] [Related]

  • 55. Rare detection of occult hepatitis B virus infection in children of mothers with positive hepatitis B surface antigen.
    Liu Y, Wen J, Chen J, Xu C, Hu Y, Zhou YH.
    PLoS One; 2014 Dec 13; 9(11):e112803. PubMed ID: 25383543
    [Abstract] [Full Text] [Related]

  • 56. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Med Virol; 2002 Oct 13; 68(2):216-20. PubMed ID: 12210410
    [Abstract] [Full Text] [Related]

  • 57. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N.
    J Med Virol; 2008 Apr 13; 80(4):577-82. PubMed ID: 18297707
    [Abstract] [Full Text] [Related]

  • 58. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec 13; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 59. Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt.
    Kishk R, Nemr N, Elkady A, Mandour M, Aboelmagd M, Ramsis N, Hassan M, Soliman N, Iijima S, Murakami S, Tanaka Y, Ragheb M.
    Virol J; 2015 Sep 30; 12():153. PubMed ID: 26420301
    [Abstract] [Full Text] [Related]

  • 60. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
    Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL.
    J Acquir Immune Defic Syndr; 2007 Mar 01; 44(3):315-20. PubMed ID: 17159655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.